Safety, tolerability, and preliminary immunogenicity of a recombinant Staphylococcus aureus vaccine (RSAV) in healthy adults between 18 and 65 years in China: study protocol for a randomized, double-blind, placebo-controlled, phase 1 trial

2017 ◽  
Vol 1 ◽  
pp. 25-25
Author(s):  
Yuan-Yuan Zhu ◽  
Jing-Xin Li ◽  
Hao Zeng ◽  
Ming Zeng ◽  
Fan-Yue Meng ◽  
...  
Keyword(s):  
Staphylococcus Aureus ◽  
Study Protocol ◽  
Phase 1 ◽  
Healthy Adults ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 1 Trial ◽  
China Study

scholarly journals H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial

2016 ◽  
Vol 16 (3) ◽  
pp. 303-310 ◽  
Author(s):  
Larisa Rudenko ◽  
Irina Isakova-Sivak ◽  
Anatoly Naykhin ◽  
Irina Kiseleva ◽  
Marina Stukova ◽  
...  
Keyword(s):  
Influenza Vaccine ◽  
Phase 1 ◽  
Healthy Adults ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 1 Trial ◽  
Live Attenuated Influenza Vaccine

scholarly journals A Randomized Double‐Blind Placebo‐Controlled First‐In‐Human Phase 1 Trial of TransCon PTH in Healthy Adults

2020 ◽  
Vol 35 (8) ◽  
pp. 1430-1440
Author(s):  
David B Karpf ◽  
Susanne Pihl ◽  
Sanchita Mourya ◽  
Eva Mortensen ◽  
Eshwari Kovoor ◽  
...  
Keyword(s):  
Phase 1 ◽  
Healthy Adults ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Phase 1 Trial
Sign in / Sign up

Export Citation Format

Share Document